Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Budi Starch Sweetener Tbk (BUDI) vs Mizuho Leasing Indonesia Tbk. (VRNA) Price & Performance

Budi Starch Sweetener TbkTrade
Mizuho Leasing Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Budi Starch Sweetener Tbk vs Mizuho Leasing Indonesia Tbk. — how do they compare? Budi Starch Sweetener Tbk trades at Rp206 (market cap 935.79B, 20.1K 24h volume), while Mizuho Leasing Indonesia Tbk. trades at Rp75 (market cap 426.55B, 1.06M 24h volume). The key difference: Budi Starch Sweetener Tbk is far larger — about 2.2× Mizuho Leasing Indonesia Tbk.'s market cap, and Mizuho Leasing Indonesia Tbk. is more actively traded (1.06M versus 20.1K). Which is the better fit depends on your goals.

BUDIVRNA
Market Cap
935.79B426.55B
Volume
20.1K1.06M
Lot
20110.63K
Turnover
4.18M82.27M
Average Price
207.7277.4
Value
4.18M82.27M
Indicative Equilibrium Price
20875
Indicative Equilibrium Volume
13.8K90

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BUDI
View details
VRNA
View details

About Budi Starch Sweetener Tbk

PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.

Read more on BUDI

About Mizuho Leasing Indonesia Tbk.

PT Verena Oto Finance (the Company) was established under its original name of PT Maxima Perdana Finance base on notarial deed No.43 of Mrs Sri Nanning, S.H, dated on Jul 21, 1993. The Companys articles of association has been amended several times, most recently by notarial deed No. 32 of Fathiah Helmi, S.H., dated Mar 26, 2007, concerning among others, the change in the Companys name, increase authorized, change in par value, and increase paid-up capital.

Read more on VRNA